Peter Hillmen, MBChb, PhD, FRCP, FRCPath from St. James’ University Hospital, Leeds, UK discusses allogeneic stem cell transplantation for chronic lymphocytic leukemia (CLL). According to Prof. Hillmen, allogeneic stem cell transplantation is the only therapy that can cure a minority of patients. However, there are side effects associated with a transplant, such as graft-versus-host disease (GvHD), and therefore it is not the treatment of choice. Recorded at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark.
The role of allogeneic stem cell transplantation in CLL
